We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIG
1526
DELISTED
Big Lots, Inc.
BIG
$2.17M ﹤0.01%
44,853
+652
+1% +$31.7K
PNQI icon
1527
Invesco NASDAQ Internet ETF
PNQI
$542M
$2.15M ﹤0.01%
104,165
-910
-0.9% -$18.4K
THW
1528
abrdn World Healthcare Fund
THW
$539M
$2.14M ﹤0.01%
141,741
+25,250
+22% +$367K
ALRM icon
1529
Alarm.com
ALRM
$2.8B
$2.14M ﹤0.01%
56,898
+4,688
+9% +$157K
BLKB icon
1530
Blackbaud
BLKB
$2.08B
$2.14M ﹤0.01%
24,973
-609
-2% -$50K
DB icon
1531
Deutsche Bank
DB
$71.5B
$2.13M ﹤0.01%
117,914
-33,877
-22% -$599K
GG
1532
DELISTED
Goldcorp Inc
GG
$2.13M ﹤0.01%
164,878
+14,183
+9% +$198K
EINC icon
1533
VanEck Energy Income ETF
EINC
$80.4M
$2.13M ﹤0.01%
30,051
-483
-2% -$35.8K
OPK icon
1534
Opko Health
OPK
$1.01B
$2.13M ﹤0.01%
323,006
-178,500
-36% -$1.25M
QRVO icon
1535
Qorvo
QRVO
$8.4B
$2.12M ﹤0.01%
33,551
-1,937
-5% -$138K
GMS
1536
DELISTED
GMS Inc
GMS
$2.12M ﹤0.01%
+75,315
New +$2.53M
MXL icon
1537
MaxLinear
MXL
$6.12B
$2.11M ﹤0.01%
75,782
+6,060
+9% +$177K
FE icon
1538
FirstEnergy
FE
$27.7B
$2.1M ﹤0.01%
72,191
+22,187
+44% +$659K
QSR icon
1539
Restaurant Brands International
QSR
$25.8B
$2.1M ﹤0.01%
33,642
+7,750
+30% +$457K
SUSA icon
1540
iShares ESG Optimized MSCI USA ETF
SUSA
$4.16B
$2.1M ﹤0.01%
41,084
+24,530
+148% +$1.23M
AXE
1541
DELISTED
Anixter International Inc
AXE
$2.1M ﹤0.01%
26,815
-88
-0.3% -$6.87K
AMSF icon
1542
AMERISAFE
AMSF
$558M
$2.1M ﹤0.01%
36,802
+11,768
+47% +$671K
AA icon
1543
Alcoa
AA
$12.6B
$2.09M ﹤0.01%
64,122
+41,302
+181% +$1.34M
CERS icon
1544
Cerus
CERS
$457M
$2.09M ﹤0.01%
833,434
+55,750
+7% +$178K
KBWY icon
1545
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$309M
$2.09M ﹤0.01%
56,095
+2,768
+5% +$104K
SABA
1546
Saba Capital Income & Opportunities Fund II
SABA
$224M
$2.09M ﹤0.01%
155,418
+2,543
+2% +$33.8K
AMC icon
1547
AMC Entertainment Holdings
AMC
$2.38B
$2.09M ﹤0.01%
9,180
+2,603
+40% +$699K
SUN icon
1548
Sunoco
SUN
$13.8B
$2.09M ﹤0.01%
68,211
+5,228
+8% +$156K
IDTI
1549
DELISTED
Integrated Device Technology I
IDTI
$2.09M ﹤0.01%
80,907
+19,231
+31% +$468K
PSI icon
1550
Invesco Semiconductors ETF
PSI
$2.4B
$2.08M ﹤0.01%
149,886
-3,048
-2% -$43.9K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.